Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1997 Oct;179(20):6453–6463. doi: 10.1128/jb.179.20.6453-6463.1997

Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides.

A P Moran 1, B Lindner 1, E J Walsh 1
PMCID: PMC179563  PMID: 9335296

Abstract

The chemical structure of free lipid A isolated from rough- and smooth-form lipopolysaccharides (R-LPS and S-LPS, respectively) of the human gastroduodenal pathogen Helicobacter pylori was elucidated by compositional and degradative analysis, nuclear magnetic resonance spectroscopy, and mass spectrometry. The predominant molecular species in both lipid A components are identical and tetraacylated, but a second molecular species which is hexaacylated is also present in lipid A from S-LPS. Despite differences in substitution by acyl chains, the hydrophilic backbone of the molecules consisted of beta(1,6)-linked D-glucosamine (GlcN) disaccharide 1-phosphate. Because of microheterogeneity, nonstoichiometric amounts of ethanolamine-phosphate were also linked to the glycosidic hydroxyl group. In S-LPS, but not in R-LPS, the hydroxyl group at position 4' was partially substituted by another phosphate group. Considerable variation in the distribution of fatty acids on the lipid A backbone was revealed by laser desorption mass spectrometry. In tetraacyl lipid A, the amino group of the reducing GlcN carried (R)-3-hydroxyoctadecanoic acid (position 2), that of the nonreducing GlcN carried (R)-3-(octadecanoyloxy)octadecanoic acid (position 2'), and ester-bound (R)-3-hydroxyhexadecanoic acid was attached at position 3. Hexaacyl lipid A had a similar substitution by fatty acids, but in addition, ester-bound (R)-3-(dodecanoyloxy)hexadecanoic acid or (R)-3(tetradecanoyloxy)hexadecanoic acid was attached at position 3'. The predominant absence of ester-bound 4'-phosphate and the presence of tetraacyl lipid A with fatty acids of 16 to 18 carbons in length differentiate H. pylori lipid A from that of other bacterial species and help explain the low endotoxic and biological activities of H. pylori LPS.

Full Text

The Full Text of this article is available as a PDF (1.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aspinall G. O., Monteiro M. A. Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions. Biochemistry. 1996 Feb 20;35(7):2498–2504. doi: 10.1021/bi951853k. [DOI] [PubMed] [Google Scholar]
  2. Aspinall G. O., Monteiro M. A., Pang H., Walsh E. J., Moran A. P. Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions. Biochemistry. 1996 Feb 20;35(7):2489–2497. doi: 10.1021/bi951852s. [DOI] [PubMed] [Google Scholar]
  3. Baker P. J., Hraba T., Taylor C. E., Stashak P. W., Fauntleroy M. B., Zähringer U., Takayama K., Sievert T. R., Hronowski X., Cotter R. J. Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides. Infect Immun. 1994 Jun;62(6):2257–2269. doi: 10.1128/iai.62.6.2257-2269.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Birkholz S., Knipp U., Nietzki C., Adamek R. J., Opferkuch W. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunol Med Microbiol. 1993 Apr;6(4):317–324. doi: 10.1111/j.1574-695X.1993.tb00344.x. [DOI] [PubMed] [Google Scholar]
  5. Blaser M. J. Helicobacter pylori: microbiology of a 'slow' bacterial infection. Trends Microbiol. 1993 Oct;1(7):255–260. doi: 10.1016/0966-842x(93)90047-u. [DOI] [PubMed] [Google Scholar]
  6. Caroff M., Tacken A., Szabó L. Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the "isolated lipid A" fragment of the Bordetella pertussis endotoxin. Carbohydr Res. 1988 Apr 15;175(2):273–282. doi: 10.1016/0008-6215(88)84149-1. [DOI] [PubMed] [Google Scholar]
  7. Chester I. R., Murray R. G. Analysis of the cell wall and lipopolysaccharide of Spirillum serpens. J Bacteriol. 1975 Dec;124(3):1168–1176. doi: 10.1128/jb.124.3.1168-1176.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Darveau R. P., Cunningham M. D., Bailey T., Seachord C., Ratcliffe K., Bainbridge B., Dietsch M., Page R. C., Aruffo A. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect Immun. 1995 Apr;63(4):1311–1317. doi: 10.1128/iai.63.4.1311-1317.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Forman D., Newell D. G., Fullerton F., Yarnell J. W., Stacey A. R., Wald N., Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. 1991 Jun 1;302(6788):1302–1305. doi: 10.1136/bmj.302.6788.1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Galanos C., Lehmann V., Lüderitz O., Rietschel E. T., Westphal O., Brade H., Brade L., Freudenberg M. A., Hansen-Hagge T., Lüderitz T. Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur J Biochem. 1984 Apr 16;140(2):221–227. doi: 10.1111/j.1432-1033.1984.tb08090.x. [DOI] [PubMed] [Google Scholar]
  11. Graham D. Y., Lew G. M., Klein P. D., Evans D. G., Evans D. J., Jr, Saeed Z. A., Malaty H. M. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992 May 1;116(9):705–708. doi: 10.7326/0003-4819-116-9-705. [DOI] [PubMed] [Google Scholar]
  12. Hase S., Rietschel E. T. Isolation and analysis of the lipid A backbone. Lipid A structure of lipopolysaccharides from various bacterial groups. Eur J Biochem. 1976 Mar 16;63(1):101–107. doi: 10.1111/j.1432-1033.1976.tb10212.x. [DOI] [PubMed] [Google Scholar]
  13. Helander I. M., Kilpeläinen I., Vaara M., Moran A. P., Lindner B., Seydel U. Chemical structure of the lipid A component of lipopolysaccharides of the genus Pectinatus. Eur J Biochem. 1994 Aug 15;224(1):63–70. doi: 10.1111/j.1432-1033.1994.tb19995.x. [DOI] [PubMed] [Google Scholar]
  14. Helander I. M., Lindner B., Brade H., Altmann K., Lindberg A. A., Rietschel E. T., Zähringer U. Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. Description of a novel deep-rough chemotype. Eur J Biochem. 1988 Nov 15;177(3):483–492. doi: 10.1111/j.1432-1033.1988.tb14398.x. [DOI] [PubMed] [Google Scholar]
  15. Holst O., Borowiak D., Weckesser J., Mayer H. Structural studies on the phosphate-free lipid A of Rhodomicrobium vannielii ATCC 17100. Eur J Biochem. 1983 Dec 1;137(1-2):325–332. doi: 10.1111/j.1432-1033.1983.tb07832.x. [DOI] [PubMed] [Google Scholar]
  16. Homma J. Y., Matsuura M., Kanegasaki S., Kawakubo Y., Kojima Y., Shibukawa N., Kumazawa Y., Yamamoto A., Tanamoto K., Yasuda T. Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J Biochem. 1985 Aug;98(2):395–406. doi: 10.1093/oxfordjournals.jbchem.a135294. [DOI] [PubMed] [Google Scholar]
  17. Johne B., Olsen I., Bryn K. Fatty acids and sugars in lipoplysaccharides from Bacteroides intermedius. Bacteroides gingivalis and Bacteroides loescheii. Oral Microbiol Immunol. 1988 Mar;3(1):22–27. doi: 10.1111/j.1399-302x.1988.tb00600.x. [DOI] [PubMed] [Google Scholar]
  18. Kanegasaki S., Kojima Y., Matsuura M., Homma J. Y., Yamamoto A., Kumazawa Y., Tanamoto K., Yasuda T., Tsumita T., Imoto M. Biological activities of analogues of lipid A based chemically on the revised structural model. Comparison of mediator-inducing, immunomodulating and endotoxic activities. Eur J Biochem. 1984 Sep 3;143(2):237–242. doi: 10.1111/j.1432-1033.1984.tb08364.x. [DOI] [PubMed] [Google Scholar]
  19. Kanegasaki S., Tanamoto K., Yasuda T., Homma J. Y., Matsuura M., Nakatsuka M., Kumazawa Y., Yamamoto A., Shiba T., Kusumoto S. Structure-activity relationship of lipid A: comparison of biological activities of natural and synthetic lipid A's with different fatty acid compositions. J Biochem. 1986 Apr;99(4):1203–1210. doi: 10.1093/oxfordjournals.jbchem.a135583. [DOI] [PubMed] [Google Scholar]
  20. Kotani S., Takada H., Tsujimoto M., Ogawa T., Harada K., Mori Y., Kawasaki A., Tanaka A., Nagao S., Tanaka S. Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A. Infect Immun. 1984 Jul;45(1):293–296. doi: 10.1128/iai.45.1.293-296.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kotani S., Takada H., Tsujimoto M., Ogawa T., Takahashi I., Ikeda T., Otsuka K., Shimauchi H., Kasai N., Mashimo J. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant. Infect Immun. 1985 Jul;49(1):225–237. doi: 10.1128/iai.49.1.225-237.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Krauss J. H., Seydel U., Weckesser J., Mayer H. Structural analysis of the nontoxic lipid A of Rhodobacter capsulatus 37b4. Eur J Biochem. 1989 Apr 1;180(3):519–526. doi: 10.1111/j.1432-1033.1989.tb14677.x. [DOI] [PubMed] [Google Scholar]
  23. Kulshin V. A., Zähringer U., Lindner B., Jäger K. E., Dmitriev B. A., Rietschel E. T. Structural characterization of the lipid A component of Pseudomonas aeruginosa wild-type and rough mutant lipopolysaccharides. Eur J Biochem. 1991 Jun 15;198(3):697–704. doi: 10.1111/j.1432-1033.1991.tb16069.x. [DOI] [PubMed] [Google Scholar]
  24. Kumada H., Haishima Y., Umemoto T., Tanamoto K. Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis. J Bacteriol. 1995 Apr;177(8):2098–2106. doi: 10.1128/jb.177.8.2098-2106.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kumazawa Y., Nakatsuka M., Takimoto H., Furuya T., Nagumo T., Yamamoto A., Homma Y., Inada K., Yoshida M., Kiso M. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity. Infect Immun. 1988 Jan;56(1):149–155. doi: 10.1128/iai.56.1.149-155.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. LOWRY O. H., ROBERTS N. R., LEINER K. Y., WU M. L., FARR A. L. The quantitative histochemistry of brain. I. Chemical methods. J Biol Chem. 1954 Mar;207(1):1–17. [PubMed] [Google Scholar]
  27. Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
  28. Moran A. P. Cell surface characteristics of Helicobacter pylori. FEMS Immunol Med Microbiol. 1995 Feb;10(3-4):271–280. doi: 10.1111/j.1574-695X.1995.tb00043.x. [DOI] [PubMed] [Google Scholar]
  29. Moran A. P., Helander I. M., Kosunen T. U. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol. 1992 Feb;174(4):1370–1377. doi: 10.1128/jb.174.4.1370-1377.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Moran A. P. The role of lipopolysaccharide in Helicobacter pylori pathogenesis. Aliment Pharmacol Ther. 1996 Apr;10 (Suppl 1):39–50. doi: 10.1046/j.1365-2036.1996.22164004.x. [DOI] [PubMed] [Google Scholar]
  31. Moran A. P., Zähringer U., Seydel U., Scholz D., Stütz P., Rietschel E. T. Structural analysis of the lipid A component of Campylobacter jejuni CCUG 10936 (serotype O:2) lipopolysaccharide. Description of a lipid A containing a hybrid backbone of 2-amino-2-deoxy-D-glucose and 2,3-diamino-2,3-dideoxy-D-glucose. Eur J Biochem. 1991 Jun 1;198(2):459–469. doi: 10.1111/j.1432-1033.1991.tb16036.x. [DOI] [PubMed] [Google Scholar]
  32. Muotiala A., Helander I. M., Pyhälä L., Kosunen T. U., Moran A. P. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun. 1992 Apr;60(4):1714–1716. doi: 10.1128/iai.60.4.1714-1716.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Parsonnet J., Hansen S., Rodriguez L., Gelb A. B., Warnke R. A., Jellum E., Orentreich N., Vogelman J. H., Friedman G. D. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994 May 5;330(18):1267–1271. doi: 10.1056/NEJM199405053301803. [DOI] [PubMed] [Google Scholar]
  34. Pérez-Pérez G. I., Shepherd V. L., Morrow J. D., Blaser M. J. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect Immun. 1995 Apr;63(4):1183–1187. doi: 10.1128/iai.63.4.1183-1187.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Raetz C. R. Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction. J Bacteriol. 1993 Sep;175(18):5745–5753. doi: 10.1128/jb.175.18.5745-5753.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Raetz C. R. Biochemistry of endotoxins. Annu Rev Biochem. 1990;59:129–170. doi: 10.1146/annurev.bi.59.070190.001021. [DOI] [PubMed] [Google Scholar]
  37. Raetz C. R., Purcell S., Meyer M. V., Qureshi N., Takayama K. Isolation and characterization of eight lipid A precursors from a 3-deoxy-D-manno-octylosonic acid-deficient mutant of Salmonella typhimurium. J Biol Chem. 1985 Dec 25;260(30):16080–16088. [PubMed] [Google Scholar]
  38. Ray B. L., Raetz C. R. The biosynthesis of gram-negative endotoxin. A novel kinase in Escherichia coli membranes that incorporates the 4'-phosphate of lipid A. J Biol Chem. 1987 Jan 25;262(3):1122–1128. [PubMed] [Google Scholar]
  39. Rietschel E. T., Brade L., Schade U., Galanos C., Freudenberg M., Lüderitz O., Kusumoto S., Shiba T. Endotoxic properties of synthetic pentaacyl lipid A precursor Ib and a structural isomer. Eur J Biochem. 1987 Nov 16;169(1):27–31. doi: 10.1111/j.1432-1033.1987.tb13576.x. [DOI] [PubMed] [Google Scholar]
  40. Rietschel E. T., Gottert H., Lüderitz O., Westphal O. Nature and linkages of the fatty acids present in the lipid-A component of Salmonella lipopolysaccharides. Eur J Biochem. 1972 Jul 13;28(2):166–173. doi: 10.1111/j.1432-1033.1972.tb01899.x. [DOI] [PubMed] [Google Scholar]
  41. Rietschel E. T., Kirikae T., Schade F. U., Mamat U., Schmidt G., Loppnow H., Ulmer A. J., Zähringer U., Seydel U., Di Padova F. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994 Feb;8(2):217–225. doi: 10.1096/fasebj.8.2.8119492. [DOI] [PubMed] [Google Scholar]
  42. STROMINGER J. L., PARK J. T., THOMPSON R. E. Composition of the cell wall of Staphylococcus aureus: its relation to the mechanism of action of penicillin. J Biol Chem. 1959 Dec;234:3263–3268. [PubMed] [Google Scholar]
  43. Sakamoto S., Watanabe T., Tokumaru T., Takagi H., Nakazato H., Lloyd K. O. Expression of Lewisa, Lewisb, Lewisx, Lewisy, siayl-Lewisa, and sialyl-Lewisx blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res. 1989 Feb 1;49(3):745–752. [PubMed] [Google Scholar]
  44. Semeraro N., Montemurro P., Piccoli C., Muolo V., Colucci M., Giuliani G., Fumarola D., Pece S., Moran A. P. Effect of Helicobacter pylori lipopolysaccharide (LPS) and LPS derivatives on the production of tissue factor and plasminogen activator inhibitor type 2 by human blood mononuclear cells. J Infect Dis. 1996 Dec;174(6):1255–1260. doi: 10.1093/infdis/174.6.1255. [DOI] [PubMed] [Google Scholar]
  45. Sidorczyk Z., Zähringer U., Rietschel E. T. Chemical structure of the lipid A component of the lipopolysaccharide from a Proteus mirabilis Re-mutant. Eur J Biochem. 1983 Dec 1;137(1-2):15–22. doi: 10.1111/j.1432-1033.1983.tb07789.x. [DOI] [PubMed] [Google Scholar]
  46. Sonesson A., Jantzen E., Bryn K., Larsson L., Eng J. Chemical composition of a lipopolysaccharide from Legionella pneumophila. Arch Microbiol. 1989;153(1):72–78. doi: 10.1007/BF00277544. [DOI] [PubMed] [Google Scholar]
  47. Stellner K., Saito H., Hakomori S. I. Determination of aminosugar linkages in glycolipids by methylation. Aminosugar linkages of ceramide pentasaccharides of rabbit erythrocytes and of Forssman antigen. Arch Biochem Biophys. 1973 Apr;155(2):464–472. doi: 10.1016/0003-9861(73)90138-0. [DOI] [PubMed] [Google Scholar]
  48. Tarkkanen J., Kosunen T. U., Saksela E. Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infect Immun. 1993 Jul;61(7):3012–3016. doi: 10.1128/iai.61.7.3012-3016.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Taylor D. N., Blaser M. J. The epidemiology of Helicobacter pylori infection. Epidemiol Rev. 1991;13:42–59. doi: 10.1093/oxfordjournals.epirev.a036078. [DOI] [PubMed] [Google Scholar]
  50. Weintraub A., Zähringer U., Wollenweber H. W., Seydel U., Rietschel E. T. Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem. 1989 Aug 1;183(2):425–431. doi: 10.1111/j.1432-1033.1989.tb14945.x. [DOI] [PubMed] [Google Scholar]
  51. Wollenweber H. W., Broady K. W., Lüderitz O., Rietschel E. T. The chemical structure of lipid A. Demonstration of amide-linked 3-acyloxyacyl residues in Salmonella minnesota Re lipopolysaccharide. Eur J Biochem. 1982 May;124(1):191–198. doi: 10.1111/j.1432-1033.1982.tb05924.x. [DOI] [PubMed] [Google Scholar]
  52. Wollenweber H. W., Seydel U., Lindner B., Lüderitz O., Rietschel E. T. Nature and location of amide-bound (R)-3-acyloxyacyl groups in lipid A of lipopolysaccharides from various gram-negative bacteria. Eur J Biochem. 1984 Dec 3;145(2):265–272. doi: 10.1111/j.1432-1033.1984.tb08547.x. [DOI] [PubMed] [Google Scholar]
  53. Zähringer U., Lindner B., Rietschel E. T. Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. Adv Carbohydr Chem Biochem. 1994;50:211–276. [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES